Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123991633 | 12399163 | 3 | F | 20160326 | 20160801 | 20160524 | 20160805 | EXP | DK-DKMA-ADR 23449427 | DK-PFIZER INC-3274859 | PFIZER | 61.00 | YR | F | Y | 0.00000 | 20160805 | CN | GB | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123991633 | 12399163 | 1 | PS | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | 1 G, DAILY | N | 90940 | 1 | G | POWDER FOR INJECTION | ||||||
| 123991633 | 12399163 | 2 | SS | CIPROFLOXACIN FRESENIUS KABI /00697203/ | CIPROFLOXACIN | 1 | Intravenous (not otherwise specified) | 400 MG, 2X/DAY | 12000 | MG | N | 0 | 400 | MG | SOLUTION FOR INFUSION | BID | |||
| 123991633 | 12399163 | 3 | SS | FLUCONAZOL HEXAL | FLUCONAZOLE | 1 | Oral | 100 MG, 1X/DAY | 400 | MG | N | 0 | 100 | MG | CAPSULE, HARD | QD | |||
| 123991633 | 12399163 | 4 | SS | VANCOMYCINE FRESENIUS KABI | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 1 G, 2X/DAY | 8 | G | N | 0 | 1 | G | POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION | BID | |||
| 123991633 | 12399163 | 5 | C | B-COMBIN | 2 | UNK | 0 | ||||||||||||
| 123991633 | 12399163 | 6 | C | FURIX | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 123991633 | 12399163 | 7 | C | KALEORID | POTASSIUM CHLORIDE | 1 | UNK | 0 | |||||||||||
| 123991633 | 12399163 | 8 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 123991633 | 12399163 | 9 | C | ALDACTONE | SPIRONOLACTONE | 1 | UNK | 0 | |||||||||||
| 123991633 | 12399163 | 10 | C | THIAMIN | THIAMINE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123991633 | 12399163 | 1 | Urosepsis |
| 123991633 | 12399163 | 2 | Urosepsis |
| 123991633 | 12399163 | 3 | Fungal infection |
| 123991633 | 12399163 | 4 | Urosepsis |
| 123991633 | 12399163 | 6 | Diuretic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123991633 | 12399163 | HO |
| 123991633 | 12399163 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123991633 | 12399163 | Acidosis | |
| 123991633 | 12399163 | Blister | |
| 123991633 | 12399163 | Cardiovascular insufficiency | |
| 123991633 | 12399163 | Dialysis | |
| 123991633 | 12399163 | Endotracheal intubation | |
| 123991633 | 12399163 | Fluid overload | |
| 123991633 | 12399163 | Hepatic failure | |
| 123991633 | 12399163 | Hypotension | |
| 123991633 | 12399163 | Rash pruritic | |
| 123991633 | 12399163 | Renal failure | |
| 123991633 | 12399163 | Toxic epidermal necrolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123991633 | 12399163 | 1 | 20160320 | 20160329 | 0 | |
| 123991633 | 12399163 | 2 | 20160318 | 20160401 | 0 | |
| 123991633 | 12399163 | 3 | 20160329 | 20160401 | 0 | |
| 123991633 | 12399163 | 4 | 20160326 | 20160329 | 0 | |
| 123991633 | 12399163 | 5 | 20160419 | 0 | ||
| 123991633 | 12399163 | 6 | 20160201 | 20160331 | 0 | |
| 123991633 | 12399163 | 7 | 20160331 | 0 | ||
| 123991633 | 12399163 | 8 | 20160310 | 0 | ||
| 123991633 | 12399163 | 9 | 20160324 | 20160331 | 0 | |
| 123991633 | 12399163 | 10 | 20160419 | 0 |